- Home
- RPRX vs CFLT Comparison
RPRX vs CFLT Comparison
Compare RPRX & CFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- CFLT
- Stock Information
- Founded
- RPRX 1996
- CFLT 2014
- Country
- RPRX United States
- CFLT United States
- Employees
- RPRX N/A
- CFLT N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- CFLT EDP Services
- Sector
- RPRX Health Care
- CFLT Technology
- Exchange
- RPRX Nasdaq
- CFLT Nasdaq
- Market Cap
- RPRX 14.2B
- CFLT 12.3B
- IPO Year
- RPRX 2020
- CFLT 2021
- Fundamental
- Price
- RPRX $31.13
- CFLT $23.44
- Analyst Decision
- RPRX Strong Buy
- CFLT Buy
- Analyst Count
- RPRX 5
- CFLT 29
- Target Price
- RPRX $41.60
- CFLT $35.17
- AVG Volume (30 Days)
- RPRX 4.3M
- CFLT 5.7M
- Earning Date
- RPRX 05-08-2025
- CFLT 05-06-2025
- Dividend Yield
- RPRX 2.83%
- CFLT N/A
- EPS Growth
- RPRX N/A
- CFLT N/A
- EPS
- RPRX 1.91
- CFLT N/A
- Revenue
- RPRX $2,263,576,000.00
- CFLT $963,642,000.00
- Revenue This Year
- RPRX $33.46
- CFLT $23.28
- Revenue Next Year
- RPRX $4.44
- CFLT $20.79
- P/E Ratio
- RPRX $16.28
- CFLT N/A
- Revenue Growth
- RPRX N/A
- CFLT 24.03
- 52 Week Low
- RPRX $24.05
- CFLT $17.79
- 52 Week High
- RPRX $34.20
- CFLT $37.90
- Technical
- Relative Strength Index (RSI)
- RPRX 33.61
- CFLT 33.89
- Support Level
- RPRX $32.26
- CFLT $25.66
- Resistance Level
- RPRX $34.14
- CFLT $27.67
- Average True Range (ATR)
- RPRX 0.76
- CFLT 1.11
- MACD
- RPRX -0.33
- CFLT -0.20
- Stochastic Oscillator
- RPRX 14.00
- CFLT 15.45
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About CFLT Confluent Inc.
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.